UnitedHealth Group (NYSE:UNH - Get Free Report) had its price target lowered by equities research analysts at Truist Financial from $660.00 to $580.00 in a research note issued to investors on Monday,Benzinga reports. The brokerage currently has a "buy" rating on the healthcare conglomerate's stock. Truist Financial's price target would indicate a potential upside of 36.57% from the stock's previous close.
A number of other research analysts also recently weighed in on the stock. Hsbc Global Res upgraded shares of UnitedHealth Group from a "hold" rating to a "strong-buy" rating in a report on Friday, January 10th. Mizuho boosted their price target on UnitedHealth Group from $600.00 to $650.00 and gave the company an "outperform" rating in a research note on Wednesday, April 9th. Raymond James reiterated a "strong-buy" rating and set a $540.00 price target (down previously from $635.00) on shares of UnitedHealth Group in a research report on Monday. Erste Group Bank upgraded UnitedHealth Group to a "strong-buy" rating in a research report on Wednesday, April 16th. Finally, Piper Sandler decreased their price target on shares of UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating for the company in a report on Thursday, January 2nd. Three equities research analysts have rated the stock with a hold rating, nineteen have issued a buy rating and three have assigned a strong buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of "Buy" and an average price target of $603.05.
Get Our Latest Stock Analysis on UNH
UnitedHealth Group Trading Down 0.8 %
Shares of UnitedHealth Group stock traded down $3.26 during trading hours on Monday, reaching $424.70. The stock had a trading volume of 7,608,478 shares, compared to its average volume of 4,455,390. The firm has a market capitalization of $388.48 billion, a price-to-earnings ratio of 27.40, a P/E/G ratio of 1.37 and a beta of 0.61. The firm has a 50 day simple moving average of $506.92 and a two-hundred day simple moving average of $537.23. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group has a 1 year low of $417.12 and a 1 year high of $630.73.
UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). The company had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same quarter in the prior year, the firm earned $6.91 EPS. As a group, equities research analysts anticipate that UnitedHealth Group will post 29.54 earnings per share for the current year.
Institutional Trading of UnitedHealth Group
A number of institutional investors and hedge funds have recently bought and sold shares of the business. NewSquare Capital LLC acquired a new position in UnitedHealth Group during the 4th quarter worth $25,000. Marshall & Sterling Wealth Advisors Inc. bought a new stake in shares of UnitedHealth Group in the 4th quarter worth approximately $26,000. Hurley Capital LLC bought a new stake in shares of UnitedHealth Group during the 4th quarter worth $28,000. AlphaMark Advisors LLC acquired a new position in UnitedHealth Group in the 4th quarter worth approximately $30,000. Finally, Aster Capital Management DIFC Ltd acquired a new stake in UnitedHealth Group during the 4th quarter worth about $30,000. Institutional investors and hedge funds own 87.86% of the company's stock.
UnitedHealth Group Company Profile
(
Get Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Read More

Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.